In hepatocellular carcinoma, the downregulation of FDX1 contributes to metabolic reprogramming, leading to reactive oxygen species-mediated mitochondrial autophagy and activation of the PI3K/AKT signaling pathway, resulting in poor prognosis (Sun et al., 2024). Here, FDX1 is linked to hepatocellular carcinoma.